Please assess the completion status of the following clinical trial:

Trial Title: Testosterone Replacement in Men With Diabetes and Obesity

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE4
- Number of Arms: 6.0

Eligibility Criteria:
Inclusion Criteria:~* T2D arm: Males with age 30-65 years~* Obese non-diabetic arm: Obese non-diabetic males with age 30-65 years~Exclusion Criteria:~1)Coronary event or procedure(myocardial infarction, unstable angina, coronary artery bypass, surgery or coronary angioplasty) in the previous twelve weeks; 2) PSA \> 4ng/ml; 3)Hemoglobin A1c \> 8%; 4)h/o prostate carcinoma; 5)Hepatic disease (transaminase \> 3 times normal) or cirrhosis; 6)Renal impairment (defined as GFR\<30); 7)HIV or Hepatitis C positive status; 9)Participation in any other concurrent clinical trial; 10)Any other life-threatening, non-cardiac disease; 11)Use of over the counter health supplements which contain androgens; 12)Use of an investigational agent or therapeutic regimen within 30 days of study; 13)prostate nodule or severe enlargement on digital rectal examination; 14)Use of testosterone currently or in the past 4 months; 15)Hematocrit \> 50%; 16)History of untreated severe obstructive sleep apnea(defined as apnea-hypopnea index ≥30); 17)symptoms suggestive of severe BPH; 18)Congestive heart failure, class III or IV; 20)Known to have anemia secondary to iron, B12 or folic acid deficiency; 21)bone marrow disorder such as myelodysplasia or aplastic anemia; 22) currently suffering from symptomatic depression, with or without treatment; 23) history of severe depression in the past which needed hospitalization; 24)currently suffering from foot ulcer, significant periodontal disease or any other chronic infectious condition; 25)planning to have children. 26) Subjects on testosterone or with testosterone replacement in the past 4 months will be excluded.

- Gender: MALE
- Minimum Age: 30 Years
- Maximum Age: 65 Years
- Healthy Volunteers: f

Study Arms:
- diabetes with HH-active (Type: ACTIVE_COMPARATOR): Subjects with diabetes and hypogonadotropic hypogonadism. They will be randomized to testosterone intervention.
- diabetes with normal testosterone (Type: NO_INTERVENTION): Eugonadal subjects with diabetes. They will not be treated
- obese with HH-active (Type: ACTIVE_COMPARATOR): Obese non-diabetic men hypogonadotropic hypogonadism. They will be randomized to testosterone intervention.
- obese with normal testosterone (Type: NO_INTERVENTION): Eugonadal non-diabetic obese subjects. They will not be treated
- Diabetes with HH-placebo (Type: PLACEBO_COMPARATOR): Subjects with diabetes and hypogonadotropic hypogonadism. They will be randomized to placebo.
- Obese with HH-placebo (Type: PLACEBO_COMPARATOR): Obese non-diabetic men hypogonadotropic hypogonadism. They will be randomized to placebo.

Based on this trial design, predict the completion outcome and termination type (if applicable).